Search results
14 gru 2023 · Table 1 displays the recommended oral dosage of TAMIFLU for prophylaxis of influenza in pediatric patients 1 year to 12 years of age based on body weight and provides information about prescribing the capsule or the formulation for oral suspension.
• *Children < 3 months of age: prophylaxis not recommended unless the situation is deemed critical due to limited data on use in this age group. • *Children < 7 days of age : seek specialist advice, wider spacing of doses may be required.
16 wrz 2024 · Usual Pediatric Dose for Influenza. 2 weeks to less than 1 year: 3 mg/kg orally twice a day. 1 to 12 years: Weight up to 15 kg: 30 mg orally twice a day. Weight 15.1 to 23 kg: 45 mg orally twice a day. Weight 23.1 to 40 kg: 60 mg orally twice a day. Weight at least 40.1 kg: 75 mg orally twice a day.
Dosing in Overweight and Obese Children: Dose based on measured body weight. (2) • Treatment and post-exposure prophylaxis should commence within 48 hours of symptoms
If body weight is not known, dosing by age to treat influenza (administer two doses per day) or prophylaxis (give one dose per day) for full-term infants <1 year of age may be necessary: 0 to 3 months = 12 mg per dose for treatment (not for prophylaxis); 3 to 5 months = 20 mg per dose; 6 to 11 months = 25 mg per dose.
The recommended oral dose of TAMIFLU for prophylaxis of influenza in adults and adolescents 13 years and older following close contact with an infected individual is 75 mg once daily for at...
1 paź 2021 · This statement updates the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2021–2022 influenza season.
